Low-dose, single agent weekly docetaxel is effective and well toleratet in elderly men with prostate cancer. - Scholz,M.C.; Guess,B.; Barrios,F.; Srum,S.; Leibowitz,R. (Proc Am Soc Clin Oncol, 2001)